Actively Recruiting
Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)
Led by Institut du Cancer de Montpellier - Val d'Aurelle · Updated on 2025-02-12
600
Participants Needed
1
Research Sites
949 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.
CONDITIONS
Official Title
Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over the age of 18
- Patient managed for peritoneal carcinosis from digestive origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer
- Patient eligible for at least one treatment for peritoneal carcinosis such as surgery, chemotherapy, or other treatments
- Patient agrees to all study procedures including biological and tissue sample collection
- Patient provides informed consent
You will not qualify if you...
- Patient not affiliated with the Social Protection system
- Patient unable to understand or comply with study instructions due to psychological, family, social, or geographical reasons
- Insufficient level of French to consent and respond to questionnaires
- Patient under legal guardianship
- Pregnant or breastfeeding women
- Patient treated in case of an emergency
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut du cancer de Montpellier ICM
Montpellier, France, 34298
Actively Recruiting
Research Team
A
Aurore MOUSSION
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here